Unique ID issued by UMIN | UMIN000031373 |
---|---|
Receipt number | R000035824 |
Scientific Title | Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor |
Date of disclosure of the study information | 2018/02/19 |
Last modified on | 2019/02/02 00:13:58 |
Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor
Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor
Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor
Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor
Japan |
Lesions of gastro-intestinal tract, pancreatobiliary and lymph node needed endoscopic ultrasonography(EUS) and EUS-FNA
Gastroenterology | Hepato-biliary-pancreatic medicine |
Malignancy
NO
It is aimed to verify which is useful EU-ME2/UCT-260 or SU-1/EG-580UT in EUS.
Safety,Efficacy
Drawability of EUS
Insertability and visibility for GI tract.
Complication due to this study.
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
2
Diagnosis
Device,equipment |
A doctor who has experienced EUS and EUS-FNA for more than 3 years perform EUS (using EU-ME2) in outpatient or inpatient, and EUS-FNA (using SU-1) in inpatient. Image findings, scope insertability, and visibility for GI tract are evaluated by crossover. EUS will be performed within 4 weeks after consent acquisition and EUS-FNA within 8 weeks after acquiring consent. If there is no problem after the examination, the patient will be discharged.
A doctor who has experienced EUS and EUS-FNA for more than 3 years perform EUS (using SU-1) in outpatient or inpatient, and EUS-FNA (using EU-ME2) in inpatient. Image findings, scope insertability, and visibility for GI tract are evaluated by crossover. EUS will be performed within 4 weeks after consent acquisition and EUS-FNA within 8 weeks after acquiring consent. If there is no problem after the examination, the patient will be discharged.
20 | years-old | <= |
Not applicable |
Male and Female
1)Men and women over 20 years old at the time we acquire informed consent
2)Patient who require EUS and EUS-FNA clinically(below)
Those who suspect the presence of lesions in the gastrointestinal tract, gall bladder / bile duct, pancreas, lymph node and need detailed observation.
Those who needs histopathological diagnosis of lesion.
Those who judged clinically that EUS / EUS-FNA is necessary other than the above.
1) Those who cannot obtain informed consent from this research.
2) Women who may be pregnant or have a possibility of pregnancy.
3) Those who judged inappropriate patient as research subject by the research doctor.
40
1st name | |
Middle name | |
Last name | Hajime Isomoto |
Tottori University Hospital
Department of Gastroenterology
86 Nishi-cho, Yonago, 683-8504, Japan
0859-38-6527
isomoto@med.tottori-u.ac.jp
1st name | |
Middle name | |
Last name | Hiroki Koda |
Tottori University Hospital
Department of Gastroenterology
86 Nishi-cho, Yonago, 683-8504, Japan
0859-38-6527
po.polnga.3.negaiwo.xxx@gmail.com
Tottori University
None
Self funding
NO
2018 | Year | 02 | Month | 19 | Day |
Unpublished
Completed
2016 | Year | 11 | Month | 09 | Day |
2016 | Year | 11 | Month | 09 | Day |
2018 | Year | 04 | Month | 30 | Day |
2018 | Year | 04 | Month | 30 | Day |
2019 | Year | 01 | Month | 01 | Day |
2018 | Year | 02 | Month | 19 | Day |
2019 | Year | 02 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035824